SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NKTR Drug delivery Company
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
507 31 0 NKTR
Emcee:  david nordic Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
482Arthur, I am as much frustrated as you are, or even more...because I did try toMiljenko Zuanic-8/9/2019
481Tuck, Having now read the full transcript of the CC this fiasco is now coming iArthur Radley-8/9/2019
480Mildly surprised no class action suit has been filed yet. But tomorrow's antuck-8/9/2019
479Now we know why the CEO was unloading all those shares before this news came outArthur Radley-8/8/2019
478MF Butcher Shop! investors.comMiljenko Zuanic-8/8/2019
477What was a base (May15 to May31) for +3M share short increase? What changed (negMiljenko Zuanic-6/13/2019
476Enrolment rate and centers opening rate for melanoma P3 still *confuse* all whatMiljenko Zuanic-6/4/2019
475Shares are up nearly $3.00 per share in pre-market, so Wall Street must like thArthur Radley-6/3/2019
474214 at ASCO-2019 nektar.comMiljenko Zuanic-6/1/2019
473Regorafenib for osteosarcoma: ascopubs.orgMiljenko Zuanic-5/30/2019
472That was my point/concern. And Mary mentioned on cc, only FEW more subjects to Miljenko Zuanic-5/16/2019
471Unless the sarcoma-IST data to be presented at ASCO are much, much better than tDewDiligence_on_SI-5/16/2019
470So much about accelerated approval,......... why they even mentioned at cc????Miljenko Zuanic-5/16/2019
469That trial, two centers (second is Anderson), was on my screen from day one. IncMiljenko Zuanic-5/9/2019
468They certainly devoted a lot of time to the sarcoma IST conducted by Dr. D'ADewDiligence_on_SI-5/9/2019
467Very informative 1Q cc: finance.yahoo.comMiljenko Zuanic-5/9/2019
466twitter.comMiljenko Zuanic-3/2/2019
465Cetus was swallowed by Chiron (which develop Proleukin), which was bought by NovMiljenko Zuanic-2/26/2019
464Whatever happened to Cetus and Chiron IL-2? Are they still relevant?semi_infinite -2/26/2019
463Competitor: fiercebiotech.comMiljenko Zuanic-2/26/2019
462Yes, it looks that way. Time-passed is too short to have many new updates (numbeMiljenko Zuanic-2/26/2019
461I don't know why they are having a call if its not substantially more of an ghmm-2/26/2019
460How long will they talk now, slicing 10 subjects from P1-escalation phase (this Miljenko Zuanic-2/26/2019
459<BMY and NKTR agree, evidently.> With not so strong conviction...only sinMiljenko Zuanic-2/11/2019
458BMY and NKTR agree, evidently.DewDiligence_on_SI-2/11/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News